Status:
COMPLETED
COVID-19 : Study of INFLAmmasome and PLAtelets Functions
Lead Sponsor:
University Hospital, Toulouse
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 pandemic is a severe viral sepsis characterized by the occurrence of Acute respiratory distress syndrome (ARDS) whose pathophysiology is little described
Detailed Description
The new Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic started on December 2019 in China and spreaded in worldwide. The Coronavirus disease 2019 (COVID-19) is responsible of cas...
Eligibility Criteria
Inclusion
- Patients suffering from COVID-19, hospitalized in intensive care unit and in standard care unit.
Exclusion
- Patients suffering from malignant blood disease, cryopyrinopathy, sickle cell disease, rheumatoid arthritis and Crohn's disease
Key Trial Info
Start Date :
April 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 25 2022
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04397822
Start Date
April 16 2020
End Date
May 25 2022
Last Update
July 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Toulouse
Toulouse, France, 31059